J0795 — Injection, corticorelin ovine triflutate, 1 microgram
J0795 is a HCPCS Level II code for injection, corticorelin ovine triflutate, 1 microgram. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J0795 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0795
- Long descriptor
- Injection, corticorelin ovine triflutate, 1 microgram
- Short descriptor
- Corticorelin ovine triflutal
- Added
- January 1, 2006
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0795
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0795 is not quite right, the correct code is very often within a few positions of it.
- J0751Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0752Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0759Injection, clevidipine butyrate, 1 mg
- J0760Injection, colchicine, per 1 mgterminated
- J0770Injection, colistimethate sodium, up to 150 mg
- J0775Injection, collagenase, clostridium histolyticum, 0.01 mg
- J0780Injection, prochlorperazine, up to 10 mg
- J0791Injection, crizanlizumab-tmca, 5 mg
- J0799Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
- J0800Injection, corticotropin, up to 40 unitsterminated
- J0801Injection, corticotropin (acthar gel), up to 40 units
- J0802Injection, corticotropin (ani), up to 40 units
- J0833Injection, cosyntropin, not otherwise specified, 0.25 mgterminated
- J0834Injection, cosyntropin, 0.25 mg
- J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
Questions about J0795
What is HCPCS code J0795?
J0795 is a HCPCS Level II code for injection, corticorelin ovine triflutate, 1 microgram. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0795?
The CMS HCPCS file marks J0795 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J0795 still valid?
No. J0795 was terminated on December 31, 2025 and should not be used on new claims.